A defective nuclear translocation of sXBP1 has been reported in metabolic disorders such as obesity and diabetes [32,33], indicating the potential use of IRE1α modifications, i.e., the IBF-R might prevent or control obesity. This evidence concerns the gene ERN1 and obesity due to melanocortin 4 receptor deficiency.